Drug Industry Daily

Subscribe Today!

Drug Industry Daily is the only electronic briefing that delivers coverage of developments at the FDA, FTC, HHS and other key agencies and decision-making bodies that affect the pharmaceutical industry around the world.

Each issue highlights the top issues affecting the industry including:

Patent exclusivity

Market globalization enforcement

EU pharmacovigilance

New inspection trends

Advertising practices

CAPA warning letters

Recalls

Drug Approvals

And more

Plus in every issue, subscribers receive the additional benefit of links to exclusive documents that support each article, such as draft and final guidances, 483s and warning letters, proposed rules, closeout letters, full text of proposed legislation and GAO reports.

Our 100% Money-Back Guarantee

There’s absolutely no risk to you. You get our 100% Money-Back Guarantee: If at any time, for any reason, you become dissatisfied with Drug Industry Daily, you may cancel your subscription and receive a full refund. No questions asked.

So, why wait? Become a subscriber to Drug Industry Daily today. It couldn’t be easier.

Daily, 250 issues/year, Electronic delivery.

$1,695$1,395

Bonus

Key Benefits

LINKS TO KEY DOCUMENTS — You get links to key documents that support DID's articles such as draft and final guidances, 483s and warning letters, proposed rules, closeout letter, full text of proposed legislation and GAO reports.